PM2.5 and constituent component impacts on global DNA methylation in patients with idiopathic pulmonary fibrosis

Gillian C Goobie1, Xiaoyun Li2, Christopher J Ryerson3

  • 1Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA; Simmons Center for Interstitial Lung Disease, Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Insights

Higher global DNA methylation (DNAm) in patients with idiopathic pulmonary fibrosis (IPF) is linked to increased exposure to fine particulate matter (PM2.5) and its components. This DNAm pattern may serve as a biomarker for air pollution exposure in IPF patients.

Area of Science:

  • Environmental Health
  • Epigenetics
  • Pulmonology

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease exacerbated by air pollution.
  • Altered DNA methylation (DNAm) is observed in IPF patients, but its connection to air pollution is unknown.

Purpose of the Study:

  • To investigate the association between PM2.5 exposure and its components with global DNAm in IPF patients.
  • To explore DNAm as a potential biomarker for air pollution exposure in IPF.

Main Methods:

  • Utilized peripheral blood DNA samples from IPF patients in two registries (Simmons and PFF).
  • Matched monthly air pollution data (PM2.5 and constituents) to patient locations using satellite-derived models.
  • Assessed global DNAm (%5mC) via ELISA and analyzed associations using regression models, including mediation analysis for mortality and lung function.

Main Results:

  • Higher 3-month PM2.5 exposure correlated with increased global DNAm (%5mC) in one cohort, with similar trends observed over 1 year.
  • Exposures to sulfate, nitrate, ammonium, and black carbon were associated with higher %5mC.
  • %5mC did not directly correlate with IPF mortality or lung function but mediated 2-5% of the pollutant-mortality association.

Conclusions:

  • Elevated global DNAm is a novel biomarker for PM2.5 and anthropogenic constituent exposure in IPF patients.
  • Further research is required to understand the pathogenic role of DNAm in mediating the link between air pollution and mortality in IPF.